全文获取类型
收费全文 | 265篇 |
免费 | 12篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 7篇 |
妇产科学 | 2篇 |
基础医学 | 22篇 |
口腔科学 | 6篇 |
临床医学 | 42篇 |
内科学 | 61篇 |
神经病学 | 1篇 |
特种医学 | 78篇 |
外科学 | 22篇 |
综合类 | 11篇 |
预防医学 | 11篇 |
眼科学 | 4篇 |
药学 | 40篇 |
中国医学 | 1篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 3篇 |
2021年 | 7篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 4篇 |
2016年 | 2篇 |
2015年 | 6篇 |
2014年 | 9篇 |
2013年 | 4篇 |
2012年 | 4篇 |
2011年 | 2篇 |
2010年 | 13篇 |
2009年 | 9篇 |
2008年 | 3篇 |
2007年 | 28篇 |
2006年 | 6篇 |
2005年 | 8篇 |
2003年 | 2篇 |
2002年 | 1篇 |
2001年 | 6篇 |
2000年 | 10篇 |
1999年 | 7篇 |
1998年 | 16篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 5篇 |
1994年 | 10篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 16篇 |
1988年 | 16篇 |
1987年 | 7篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1979年 | 1篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 4篇 |
1974年 | 1篇 |
排序方式: 共有321条查询结果,搜索用时 0 毫秒
51.
52.
目的:提供合适的方法,以控制梅花点舌丸的含量。方法:双波长薄层扫描法测定梅花点舌丸中华蟾蜍毒基的含量。λs=295nm,λn=370nm。在1。200-6.020μg范围内呈良好的线性(r=0.9978),同板和异板精密度试验的RSD值分别为0.092%主2.79%(n=5)。结果:平均加样回收率和RSD值分别为99.2%和1.14%(n=6),结论:本法简单、准确、可作为梅花点舌丸的质量控制方法。 相似文献
53.
54.
Internet网上细胞凋亡研究的信息资源及其利用 总被引:1,自引:0,他引:1
0 引言 Internet网上含有丰富的信息资源 ,科研人员可以通过 Internet网了解其所研究领域的最新发展动态 ,获取全面和系统的科研信息 ,有利于进行学术交流[1 ] .然而网上信息浩如烟海 ,当检索某一专门领域的资料时 ,有时无从下手 .我们在科研实践中对 Internet网上主要的细胞凋亡研究信息资源及其查找方法进行了归纳 .1 细胞凋亡专业网站1. 1 The Cell death society (http:/ / www.celldeath-apoptosis.org) 为美国细胞死亡学会主办 ,概括了细胞凋亡和程序性细胞死亡研究的各个领域 ,包括与细胞凋亡有关的各种疾病 .可以免费注册… 相似文献
55.
56.
Michelle Liu Sally Shi Sean Senthilnathan Julie Yu Elliot Wu Carsten Bergmann Klaus Zerres Nadja Bogdanova Eliecer Coto Constantinos Deltas Alkis Pierides Kyproula Demetriou Olivier Devuyst Berenice Gitomer Marku Laakso Anne Lumiaho Klea Lamnissou Riccardo Magistroni Patrick Parfrey Martijn Breuning Dorien J.M. Peters Roser Torra Christopher G. Winearls Vicente E. Torres Peter C. Harris Andrew D. Paterson York Pei 《Journal of the American Society of Nephrology : JASN》2010,21(9):1510-1520
Significant variation in the course of autosomal dominant polycystic kidney disease ( ADPKD) within families suggests the presence of effect modifiers. Recent studies of the variation within families harboring PKD1 mutations indicate that genetic background may account for 32 to 42% of the variance in estimated GFR (eGFR) before ESRD and 43 to 78% of the variance in age at ESRD onset, but the genetic modifiers are unknown. Here, we conducted a high-throughput single-nucleotide polymorphism (SNP) genotyping association study of 173 biological candidate genes in 794 white patients from 227 families with PKD1. We analyzed two primary outcomes: (1) eGFR and (2) time to ESRD (renal survival). For both outcomes, we used multidimensional scaling to correct for population structure and generalized estimating equations to account for the relatedness among individuals within the same family. We found suggestive associations between each of 12 SNPs and at least one of the renal outcomes. We genotyped these SNPs in a second set of 472 white patients from 229 families with PKD1 and performed a joint analysis on both cohorts. Three SNPs continued to show suggestive/significant association with eGFR at the Dickkopf 3 (DKK3) gene locus; no SNPs significantly associated with renal survival. DKK3 antagonizes Wnt/β-catenin signaling, which may modulate renal cyst growth. Pending replication, our study suggests that genetic variation of DKK3 may modify severity of ADPKD resulting from PKD1 mutations.Autosomal dominant polycystic kidney disease ( ADPKD) is the most common monogenic kidney disease worldwide, affecting one in 500 to 1000 births.1,2 It is characterized by focal development of renal cysts in an age-dependent manner. Typically, only a few renal cysts are clinically detectable during the first three decades of life; however, by the fifth decade, tens of thousands of renal cysts of different sizes can be found in most patients.3 Progressive cyst expansion with age leads to massive enlargement and distortion of the normal architecture of both kidneys and, ultimately, ESRD in most patients. ADPKD is also associated with an increased risk for cardiac valvular defects, colonic diverticulosis, hernias, and intracranial arterial aneurysms. Overall, ADPKD accounts for approximately 5% of ESRD in North America.2Mutations of PKD1 and PKD2 respectively account for approximately 85% and approximately 15% of linkage-characterized European families. Polycystin-1 (PC-1) and PC-2, the proteins encoded by PKD1 and PKD2, respectively, function as a macromolecular complex and regulate multiple signaling pathways to maintain the normal tubular structure and function.1 Monoclonal expansion of individual epithelial cells that have undergone a somatic “second hit” mutation, resulting in biallelic inactivation of either PKD1 or PKD2, seems to provide a major mechanism for focal cyst initiation,4 possibly through the loss of polycystin-mediated mechanosensory function in the primary cilium.5 In addition, a large prospective, observational study indicated that renal cysts in ADPKD expand exponentially with increasing age, and patients with large polycystic kidneys are at higher risk for developing kidney failure6; however, the key factors that modulate renal disease progression in ADPKD remain incompletely understood.Renal disease severity in ADPKD is highly variable, with the age of onset of ESRD ranging from childhood to old age.7–11 A strong genetic locus effect has been noted in ADPKD. Adjusted for age and gender, patients with PKD1 have larger kidneys and earlier onset at ESRD than patients with PKD2 (mean age at ESRD 53.4 versus 72.7 years, respectively).8,9 By contrast, a weak allelic effect (based on the 5′ versus 3′ location of the germline mutations) on renal disease severity may be present for PKD110 but not PKD2.11 Marked intrafamilial variability in renal disease is well documented in ADPKD and suggests a strong modifier effect.10–15 In an extreme example, large polycystic kidneys were present in utero in one of a pair of dizygotic twins affected with the same germline PKD1 mutation, whereas the kidneys of the co-twin remained normal at 5 years of age.12 Several studies have quantified the role of genetic background in the phenotypic expression of ADPKD. In a comparison of monozygotic twins and siblings, greater variance in the age of onset of ESRD in the siblings supported a role for genetic modifiers.13 Two other studies of intrafamilial disease variability in PKD1 have estimated that genetic factors may account for 32 to 42% of the variance of creatinine clearance before ESRD and 43 to 78% of the variance in age at ESRD.14,15 The magnitude of the modifier gene effect from these studies suggests that mapping such factors is feasible. Here, we report the results of an association study of modifier genes for PKD1 renal disease severity. 相似文献
57.
Koon H Chan Jason SC Kwan Philip WL Ho Jessica WM Ho Andrew CY Chu David B Ramsden 《Journal of neuroinflammation》2010,7(1):50
Background
Neuromyelitis optica spectrum disorders (NMOSD) are severe central nervous system inflammatory demyelinating disorders (CNS IDD) characterized by monophasic or relapsing, longitudinally extensive transverse myelitis (LETM) and/or optic neuritis (ON). A significant proportion of NMOSD patients are seropositive for aquaporin-4 (AQP4) autoantibodies. We compared the AQP4 autoantibody detection rates of tissue-based indirect immunofluorescence assay (IIFA) and cell-based IIFA. 相似文献58.
We have explored the polymorphism of the glycophorin system in the human erythrocyte membrane using the immunoblotting techniques and examining 52 individuals selected without prior bias as to their serologic state and ten documented serologic variants of M, N, S, s blood group system. Polyclonal antisera to alpha glycophorin and to alpha glycophorin CNBr carboxyl terminal fragment C (residues 82-131) and M and N specific monoclonal antibodies (MoAbs) were used. The first two reagents detect specific regions of the alpha glycophorin molecule and all electrophoretically resolved species of glycophorins immunologically related to alpha and delta glycophorins (delta glycophorin, [alpha-delta] hybrids and other glycophorins with an alteration in the carboxyl terminal segment); the M and N MoAbs identified the glycophorin species containing or lacking the M or N determinant in the amino terminal octapeptide structures. We find that immunoblotting confirmed in all cases the serologically determined phenotype; we also find that polymorphic forms of the glycophorin system are relatively infrequent; immunoblotting, independent from serologic testing, was capable of detecting five mutants, two most likely S-s-U-phenotypes; a new glycophorin species was detected in normal red cells with both antiglycophorin and antipeptide C sera, which is not evident with MoAbs; immunoblots of known glycophorin variants (En(a-), U-, Mg, Mi I, II, III, V, and Sta) confirmed but also extended our knowledge of the abnormal glycophorins involved; and the He+ and Wrb(-) cells showed normal patterns. 相似文献
59.
60.